Influence of valsartan combined with indapamide on the UmAlb level and blood pressure in patients with hypertension and diabetes mellitus
10.3760/cma.j.issn.1008-6706.2015.24.022
- VernacularTitle:吲达帕胺联合缬沙坦对高血压并糖尿病患者血压及尿微量白蛋白水平的影响
- Author:
Haiping WU
;
Yahong ZHANG
;
Beibei WANG
- Publication Type:Journal Article
- Keywords:
Hypertension;
Diabetes;
Indapamide;
Valsartan;
Blood pressure;
Albuminuria
- From:
Chinese Journal of Primary Medicine and Pharmacy
2015;(24):3748-3750
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the influence of valsartan combined with indapamide on the UmAlb level and blood pressure in patients with hypertension and diabetes mellitus.Methods 90 patients with hypertension and diabetes mellitus were selected and randomly divided into three groups by number table.30 cases of the control group A were treated with indapamide,30 cases of the control group B were treated with valsartan,30 cases of the observa-tion group were treated with indapamide combined with valsartan.After treatment,the clinical parameters and effect of the three groups were compared.Results After treatment,the systolic blood pressure and diastolic blood pressure of the three groups were decreased(all P <0.05),and the observation group decreased obviously(all P <0.05).The total effective rate of the observation group was 96.7%,which was higher than 86.6% of the control group A and 83.3% of the control group B(χ2 =4.1 2,4.22,all P <0.05).Conclusion In the treatment of hypertension and diabetes,the antihypertensive effect of indapamide combined with valsartan is obvious and can protect the renal func-tion,which should be promoted in clinical use.
